Mai A. Abd El Fattah

Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease

Ghada A. Badawi, Mai A. Abd El Fattah, Hala F. Zaki et al. · Inflammopharmacology · 2017 · 117 citations

Rotenone-induced Parkinson ’, Neurodegenerative Diseases, Medicine +10

Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-κB axis

Mostafa A. Rabie, Mai A. Abd El Fattah, Noha N. Nassar et al. · Biochemical Pharmacology · 2018 · 81 citations

Inflammation, Molecular Pharmacology, Hemiparkinsonian Rats +11

Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease

Hanan S. El‐Abhar, Mai A. Abd El Fattah, Walaa Wadie et al. · PLoS ONE · 2018 · 62 citations · Full text

Immune Regulation, Immunology, Cell Death +22

Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats

Ghada A. Badawi, Mai A. Abd El Fattah, Hala F. Zaki et al. · Neurotoxicity Research · 2019 · 49 citations

Attenuate Dyskinetic Movements, Rotenone-lesioned Rats, Medicine +6

Cardiorenal protective effect of taurine against cyclophosphamide-induced toxicity in albino rats

Khaled A. Alhumaidha, Dalia O. Saleh, Mai A. Abd El Fattah et al. · Canadian Journal of Physiology and Pharmacology · 2015 · 42 citations